Additionally, IL-17A has been reported to have a role in promoting tumor growth and metastasis, but it also exhibited anti-cancer ability and showed a positive function in improving response to adjuvant chemotherapy in bladder cancer and gastric cancer (Kulig et al., 2016; Wang et al., 2019; Wang Z. et al., 2020). Here, IL17A is linked to gastric cancer.